Alphabet’s drug-design company has raised $7.7 billion across three announced rounds. The next milestone is not another financing. It is a first human trial.
Isomorphic Labs raised $5 billion in a Series C announced Nov. 17, giving Alphabet’s AI drug-design company more than twice…
